Art Therapy in Acute Schizophrenia

Not Applicable

Completed

• Conditions: Schizophrenia
• Interventions: Behavioral: psychodynamic art therapy

• Registration Number: NCT01622166
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual.

\*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU.

\*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-08
• Study First Submitted: 2012-06-12
• Study First Submitted QC: 2012-06-14
• Study First Posted: 2012-06-19
• Primary Completion: 2013-01
• Study Completion: 2013-01
• Status Verified: 2014-10
• Last Update Submitted: 2014-10-22
• Last Update Posted: 2014-10-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• diagnosis of schizophrenia according to DSM-IV-TR
• age 18-64 yrs
• sufficient German language competency
• written informed consent

Exclusion Criteria

• axis-I mental disorders other than schizophrenia
• comorbid antisocial personality disorder, relevant substance abuse,
• relevant severe somatic disease
• acute suicidal tendencies or aggression
• incapability to tolerate group settings

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
art therapy	psychodynamic art therapy	12 sessions of art therapy / 6 weeks

Primary Outcome Measures

Name	Time	Method
Change in Positive and Negative Syndrome Scale (PANSS-) scores	weeks 0, 6, 12	assessment of change of schizophrenic positive, negative and general symptom scores
safety measures	weeks 0, 6, 12	number of participants with adverse events
Change in Calgary depression Scale (CDS-) scores	weeks 0, 6, 12	assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores

Trial Locations

Locations (1)

Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus; 🇩🇪 Berlin, Germany